reports
- Jonathan Moreland
LULU LULULEMON ATHLETICA INC
EPD ENTERPRISE PRODUCTS PARTNERS L.P.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
STIM STIMSONITE CORP
REEMF RARE ELEMENT RESOURCES
AHCO ADAPTHEALTH
AIRS AIRSCULPT TECHNOLOGIES INC
MNR MACH NATURAL RESOURCES LP
MXF THE MEXICO FUND
IBIO INC.
GF IBIO INC.
FMBM THE NEW GERMANY FUND
INC.
F & M BANK CORP
- Jonathan Moreland
WAT WATERS CORPORATION
VNO VORNADO REALTY TRUST
TGL. TECNOGLASS INC.
SCM STELLUS CAPITAL INVESTMENT CORP
ROCK GIBRALTAR INDUSTRIES INC.
POOL POOL CORPORATION
OSUR ORASURE TECHNOLOGIES INC.
NSP INSPERITY INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
NFBK NORTHFIELD BANCORP INC.
MTN VAIL RESORTS INC.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
CRM SALESFORCE.COM INC.
BBSI BARRETT BUSINESS SERVICES INC.
WD WALKER & DUNLOP INC.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
PLBC PLUMAS BANCORP
BWFG BANKWELL FINANCIAL GROUP
SVRA SAVARA
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
ULBI ULTRALIFE
SONO SONOS
EML THE EASTERN COMPANY
STIM STIMSONITE CORP
BLDR BUILDERS FIRSTSOURCE
AEYE INC.
PHR AUDIOEYE INC
AHCO PHREESIA
AVO ADAPTHEALTH
AMR MISSION PRODUCE
TRIN ALPHA METALLURGICAL RESOURCES INC
AIRS TRINITY CAPITAL INC
EXFY AIRSCULPT TECHNOLOGIES INC
SBSW EXPENSIFY INC
VANI SIBANYE-STILLWATER LTD
GRNT VIVANI MEDICAL INC
NBBK GRANITE RIDGE RESOURCES INC
SDHC NB BANCORP INC.
MXF SMITH DOUGLAS HOMES CORP
SNES THE MEXICO FUND
GF INC.
AFCG SENESTECH INC.
SI THE NEW GERMANY FUND
SENS INC.
AFC GAMMA
INC.
SHOULDER INNOVATIONS INC
SENSEONICS HOLDINGS INC.
OraSure Highlights Significant Operational Progress and Value Creation...
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital Company Has Demonstrated Momentum on Transformation Strategy with Significant Regulatory and Commercial Milestones Approaching in 2026 Highlights Extensive Engagement with Altai Altai Has Rejected All Settlement Proposals and Is Singularly Focused on Securing Board Representation for Its Founder to Force an Ill-Timed Sale Process BETHLEHEM, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and the “Company”) (NASDAQ: OSUR), a leader in point...
- Jonathan Moreland
WHF WHITEHORSE FINANCE INC.
VRTS VIRTUS INVESTMENT PARTNERS INC.
VNO VORNADO REALTY TRUST
TGL. TECNOGLASS INC.
ROCK GIBRALTAR INDUSTRIES INC.
OSUR ORASURE TECHNOLOGIES INC.
MTN VAIL RESORTS INC.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
FFIN FIRST FINANCIAL BANKSHARES INC
DIN DINE BRANDS GLOBAL INC.
BBSI BARRETT BUSINESS SERVICES INC.
GAM GENERAL AMERICAN INVESTORS CO. INC.
BWFG BANKWELL FINANCIAL GROUP
ULBI ULTRALIFE
BLDR BUILDERS FIRSTSOURCE
AHCO INC.
GRNT ADAPTHEALTH
TRIN GRANIT SKOPKE
AIRS TRINITY CAPITAL INC
BXSL AIRSCULPT TECHNOLOGIES INC
VANI BLACKSTONE SECURED LENDING FUND
CWBC VIVANI MEDICAL INC
MXF COMMUNITY WEST BANCSHARES NEW
SENS THE MEXICO FUND
FLNT INC.
SENSEONICS HOLDINGS INC.
FLUENT INC
OraSure Announces Fourth Quarter 2025 Financial Results
OraSure Announces Fourth Quarter 2025 Financial Results BETHLEHEM, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended December 31, 2025. “Our Q4 results were consistent with our expectations, and revenue of $26.8 million was above the midpoint of our guidance range,” said Carrie Eglinton Manner, President and CEO of OTI. “We supported our customers in navigating a challenging funding environment in 2025, and w...
OraSure to Launch OraQuick™ HIV Self-Test in Canada
OraSure to Launch OraQuick™ HIV Self-Test in Canada BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its OraQuick™ HIV Self-Test has received a license from Health Canada for use in Canada. The OraQuick™ HIV Self-Test is a point-of-care rapid antibody test. It is Canada’s first oral HIV self-test and detects antibodies for both HIV-1 and HIV-2, enabling individuals to find out their HIV status with a simple oral swab in as little as ...
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Ear...
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th BETHLEHEM, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2025 financial results and certain business developments for 5 p.m. ET on February 25, 2026. A webcast of the conference call will be available on the investor relations page of OraSure’s website at . Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The w...
OraSure Technologies Confirms Receipt of Director Nominations from Alt...
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital No Shareholder Action Required at This Time BETHLEHEM, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today confirmed that Altai Capital (“Altai”) has nominated two candidates, including the fund’s founder Rishi Bajaj, to stand for election to the Company’s Board of Directors (the “Board”) at its 2026 Annual Meeting of Stockholders. As previously announced, OraSure’s...
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collect...
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review BETHLEHEM, Pa., Jan. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) (“OraSure” and “OTI”), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that it submitted two separate applications at the end of 2025 to the U.S. Food and Drug Administration (FDA) for clearance of its rapid molecular self-test for Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) as well as its Colli-Pee™ at-home urine collection device for sexu...
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent...
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates No Shareholder Action Required at This Time BETHLEHEM, Pa., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today confirmed that Altai Capital (“Altai”) has notified the Company of its intent to nominate two candidates, including the fund’s founder, Rishi Bajaj, to stand for election to the Company’s Board of Directors (the “Board”) at its 2026 Annual ...
OraSure to Participate in Upcoming Investor Conference
OraSure to Participate in Upcoming Investor Conference BETHLEHEM, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that the company is scheduled to participate in the following investor conference: Stephens Annual Investment Conference on Wednesday, November 19, with a Q&A session scheduled for 10 a.m. CT A live webcast and replay of the Q&A session will be available on the investor relations page of OraSure’s website at . About OraSure Technologies, Inc. OraSure Technologies, Inc. (“OraSure” and “OTI”) transforms health through actionabl...
OraSure Announces Third Quarter 2025 Financial Results
OraSure Announces Third Quarter 2025 Financial Results BETHLEHEM, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended September 30, 2025. “In Q3 we delivered $27.1 million of revenue. While some of our customers continue to experience elevated levels of uncertainty related to funding for public health programs and research, we remain confident in our opportunities to return to growth in 2026, driven by divers...
OraSure to Announce Third Quarter 2025 Financial Results and Host Earn...
OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business developments for 5 p.m. ET on November 5, 2025. A webcast of the conference call will be available on the investor relations page of OraSure’s website at . Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webca...
OraSure Technologies Appoints Steven K. Boyd to its Board of Directors
OraSure Technologies Appoints Steven K. Boyd to its Board of Directors Seasoned Investor with Deep Experience in the Healthcare and Medical Device Industries Brings Valuable Capital Markets Expertise and Investor Perspective OraSure Board Has Added Three New Independent Directors in the Past Three Years Mara Aspinall to Step Down from the Board; Jack Kenny Appointed as Chair of the Board BETHLEHEM, Pa., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announc...
OraSure Announces Second Quarter 2025 Financial Results
OraSure Announces Second Quarter 2025 Financial Results BETHLEHEM, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended June 30, 2025. “Our Q2 results were consistent with our expectations. We are making significant progress on our initiatives to expand our product portfolio, including launching our novel blood collection device for proteomic research in July. We are also staying closely aligned with our custome...
OraSure Appoints Anne Messing as Chief Commercial Officer
OraSure Appoints Anne Messing as Chief Commercial Officer BETHLEHEM, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that Anne Messing has joined OTI as Chief Commercial Officer. Ms. Messing brings more than 25 years of commercial leadership experience across the healthcare industry, including in life sciences, diagnostics, and clinical laboratory services, with a proven track record of driving growth, building high-performing sales teams, and tra...
OraSure to Announce Second Quarter 2025 Financial Results and Host Ear...
OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th BETHLEHEM, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2025 financial results and certain business developments for 5 p.m. ET on August 5, 2025. A webcast of the conference call will be available on the investor relations page of OraSure’s website at . Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webca...
OraSure Launches Novel Blood Collection Device for Proteomic Research
OraSure Launches Novel Blood Collection Device for Proteomic Research The device has the potential to transform proteomic discovery through extended protein stabilization and a simplified workflow for research BETHLEHEM, Pa., July 10, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the launch of its HEMAcollect™●PROTEIN product to meet the evolving needs of proteomic researchers. The product, developed by OTI subsidiary DNA Genotek, is an evacuated blood colle...
OraSure Announces First Quarter 2025 Financial Results
OraSure Announces First Quarter 2025 Financial Results BETHLEHEM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended March 31, 2025. “Our Q1 results were consistent with our expectations. Our customers continue to demonstrate their preference for our differentiated products in delivering on their important health objectives, even while uncertainty remains elevated related to government funding sources for some ...
OraSure to Announce First Quarter 2025 Financial Results and Host Earn...
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certain business developments for 5 p.m. ET on May 7, 2025. A webcast of the conference call will be available on the investor relations page of OraSure’s website at . Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will b...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.